Viewing StudyNCT00489489



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00489489
Status: COMPLETED
Last Update Posted: 2012-11-06
First Post: 2007-06-20

Brief Title: Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Sponsor: Sanofi
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis
Keywords:
Name View
MS View
interferon-beta View
adjunctive therapy View
relapses View